Clinical Trial

Evaluation of Pulpal and Salivary Neuropeptides in Dental Pain

Study acronym: PAIN-SPCGRP
Completed
View on ClinicalTrials.gov →
Summary
This observational cross-sectional study is designed to evaluate pulpal and salivary levels of Substance P (SP) and Calcitonin Gene-Related Peptide (CGRP) in individuals with and without dental pain. The study aims to assess the associations between neuropeptide levels, pain severity, histopathological pulpal inflammation, and psychological status including depression, anxiety, and stress. By integrating biological and psychosocial parameters, this study seeks to contribute to a comprehensive understanding of the multifactorial nature of dental pain.
Trial Details
NCT Number NCT07330024
Lead Sponsor Kahramanmaras Sutcu Imam University
Conditions Dental Pain, Pulpitis, Pulpal Inflammation, Psychological Stress, Anxiety
Enrollment 72 participants
Start Date 2024-11-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-09